Universal HPV Vaccination Reduces Cervical Cancer in All Socioeconomic Groups

A British nationwide study showed >90% reduction in rates of cervical cancer and dysplasia in women vaccinated at age 12–13, regardless of social class.

In 2008, routine free human papillomavirus (HPV) vaccination was introduced in England for girls aged 12–13, including catch-up vaccination until age 19. Previous studies demonstrated greatly reduced cervical cancer incidence in HPV-vaccinated women but also showed that both acceptance and uptake of the HPV vaccine was lower among women from socioeconomically deprived areas. Now, British researchers have assessed follow-up data from the National Health Service population-based cancer registry, stratified according to HPV vaccination status and socioeconomic deprivation.

Between January 2006 and June 2020, cervical cancer and cervical intraepithelial neoplasia grade 3 (CIN3) were diagnosed in 29,968 and 335,228 women in England, respectively.…

Reviewing Author

Thomas Glück, MD

Disclosures

Editorial BoardsConsilium Infectiorum by InfectoPharm, Infection

Thomas Glück, MD

Disclosures

Editorial BoardsConsilium Infectiorum by InfectoPharm, Infection

Universal HPV Vaccination Reduces Cervical Cancer in All Socioeconomic Groups

Topics

Reviewing Author